Cortical remyelination failure predicts cortical atrophy and clinical progression in early multiple sclerosis (P2-4.008)
Andrea Lazzarotto(Centre National de la Recherche Scientifique), Benedetta Bodini(Inserm), Nicola De Stefano(University of Siena), Christian Enzinger(Medical University of Graz), Claudio Gasperini(Nini Hospital), Lukas Pirpamer(Medical University of Graz), Mattéo Tonietto(Centre National de la Recherche Scientifique), Marco Battaglini(University of Siena), Vito A. G. Ricigliano(Inserm), Maria Laura Stromillo(University of Siena), Giacomo Boffa(Centre National de la Recherche Scientifique), Michael Khalil(Medical University of Graz), Stefan Ropele(Medical University of Graz), Mariem Hamzaoui(Inserm), Bruno Stankoff(Pitié-Salpêtrière Hospital), Maria A. Rocca(Cognitive Neuroimaging Lab), Paolo Gallo(University of Padua)
Cited by 0
Related Papers
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646